Feature|Articles|October 15, 2024
- Pharmaceutical Executive: October 2024
- Volume 44
- Issue 10
Pharmaceutical Executive: October 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive October 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 1 year ago
Assembly Required: Building Blocks in Biopharmaover 1 year ago
Pharma’s Cold Calling: CGT Space at a Critical Crossroadsover 1 year ago
‘Selling a Vision’: Today’s Playbook for Startupsover 1 year ago
Rafaat Rahmani: Beating the Oddsover 1 year ago
AI: A Value Advantage? Maximizing Your Brand Outreachover 1 year ago
How to Rally a Team Around Building a New Businessover 1 year ago
Trading Quality for Convenience? The New Tech Balancing Actover 1 year ago
Amazon Targeting the Transactional in the Pharma MarketNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5

